FindTrial
Sign In

Clinical Study of Lidan Mixture on Children with Biliary Atresia after Hilar Jejunal Anastomosis

Clinical Study of Lidan Mixture on Children with Biliary Atresia after Hilar Jejunal Anastomosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005205
Enrollment
Unknown
Registered
2021-08-26
Start date
2019-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary atresia

Interventions

Control group:Conventional antibiotics, ursodeoxycholic acid, hormones and Lidan Mixture
Therapy group:Conventional antibiotics, ursodeoxycholic acid, hormones

Sponsors

Wuhan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Children with biliary atresia confirmed by surgery and pathology and undergoing Kasai surgery, aged < 120 days at the day of the first operation; 2. Can cooperate with the doctor's treatment and takes regular examinations; 3. The included patients were performed by Dr. Yan Xueqiang in the Department of General Surgery or Dr. Xiong Xiaofeng in the Department of Neonatal surgery.

Exclusion criteria

Exclusion criteria: 1. Cirrhosis with intrahepatic calculi, portal hypertension, gastrointestinal bleeding and other serious complications; 2. Complicated with severe kidney, blood system, endocrine, cardiovascular, nervous system diseases; 3. Children with liver failure.

Design outcomes

Primary

MeasureTime frame
Serum type III procollagen;Kidney function (BUN, SCR, UA);Serum hyaluronidase;Liver function (ALT, AST, TBIL, DBIL, ?-GGT);Serum type IV collagen;Serum laminin;—

Countries

China

Contacts

Public ContactXiao-Li Xiong
3112897691@qq.com+86 27 82433160

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026